Held on 14 November 2014
Saamya Biotech (India) announced that the Board of Directors of the Company at its meeting held on 14 November 2014, inter alia, has approved the application to be submitted to Stock Exchanges for Trading approval for 17,90,000 Equity shares allotted pursuant to conversion of equity warrants issued on preferential basis and authorized the Managing Director or any Director of the Company to submit the relevant information / documents to Stock Exchanges in this regard.Powered by Capital Market - Live News
